Akt and PTEN: New diagnostic markers of non-small cell lung cancer?

被引:19
|
作者
David, O [1 ]
机构
[1] Tulane Univ, Hlth Sci Ctr, New Orleans, LA 70112 USA
关键词
Akt; PTEN; cell survival; immunohistochemistry; lung cancer;
D O I
10.1111/j.1582-4934.2001.tb00178.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
We are particularly interested in testing the principles of cell proliferation and apoptosis in the microenvironment of human lung cancers with respect to the cell survival protein Akt (1) and PTEN (2). Akt is a cytosolic protein which promotes cell survival by phosphorylative inactivation of targets in apoptotic pathways. Akt has been found to play a role in the survival of experimental cancer cell lines in breast, prostate, ovary, lung and brain tissue. PTEN is a tumor suppressor gene whose protein product is expressed in inverse proportion to phosphorylated Akt in endometrial and breast cancer cell lines. No studies of the diagnostic significance of Akt and PTEN in human lung cancers have been reported.
引用
收藏
页码:430 / 433
页数:4
相关论文
共 50 条
  • [1] Phosphorylated Akt overexpression and loss of PTEN expression in non-small cell lung cancer confers poor prognosis
    Tang, JM
    He, QY
    Guo, RX
    Chang, XJ
    LUNG CANCER, 2006, 51 (02) : 181 - 191
  • [2] Therapeutic Implications of PTEN in Non-Small Cell Lung Cancer
    Sirhan, Zaid
    Alojair, Rawan
    Thyagarajan, Anita
    Sahu, Ravi P.
    PHARMACEUTICS, 2023, 15 (08)
  • [3] PTEN and phosphorylated AKT expression and prognosis in early- and late-stage non-small cell lung cancer
    Lim, W. T.
    Zhang, W. H.
    Miller, C. R.
    Watters, J. W.
    Gao, F.
    Viswanathan, A.
    Govindan, R.
    McLeod, H. L.
    ONCOLOGY REPORTS, 2007, 17 (04) : 853 - 857
  • [4] Extracellular fibrin promotes non-small cell lung cancer progression through integrin ß1/PTEN/AKT signaling
    Li, Guilong
    Cai, Jiaying
    Xie, Jianjun
    Dai, Yizhi
    OPEN LIFE SCIENCES, 2023, 18 (01):
  • [5] ANALYSIS OF PTEN MUTATION STATUS IN CHINESE PATIENTS WITH NON-SMALL CELL LUNG CANCER
    Su, Jian
    An, She-Juan
    Huang, Ying
    Chen, Shi-Liang
    Guo, Wei-Bang
    Chen, Zhi-Hong
    Tang, Hong-Yan
    Zhi, Xie
    Chen, Jian-Guang
    Zhang, Xu-Chao
    Wu, Yi-Long
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S960 - S961
  • [6] Prognostic molecular markers in non-small cell lung cancer
    Niklinski, J
    Niklinska, W
    Laudanski, J
    Chyczewska, E
    Chyczewski, L
    LUNG CANCER, 2001, 34 : S53 - S58
  • [7] Molecular diagnostics of non-small cell lung cancer. New markers and technologies
    Warth, A.
    Endris, V.
    Kriegsmann, M.
    Stenzinger, A.
    Penzel, R.
    Pfarr, N.
    Weichert, W.
    PATHOLOGE, 2015, 36 (02): : 154 - 163
  • [8] Molecular diagnostics of non-small cell lung cancer. New markers and technologies
    Warth, A.
    Endris, V.
    Kriegsmann, M.
    Stenzinger, A.
    Penzel, R.
    Pfarr, N.
    Weichert, W.
    PATHOLOGE, 2015, 36 (02): : 154 - 163
  • [9] Loss of PTEN Expression is an Independent Poor Prognostic Factor in Non-small Cell Lung Cancer
    Yoo, Seol Bong
    Xu, Xianhua
    Lee, Hyun Ju
    Jheon, Sanghoon
    Lee, Choon-Taek
    Choe, Gheeyoung
    Chung, Jin-Haeng
    KOREAN JOURNAL OF PATHOLOGY, 2011, 45 (04) : 329 - 335
  • [10] LncARSR promotes non-small-cell lung cancer progression via regulating PTEN/Akt
    Ying, Jie
    Yang, Jian
    Liu, Yingzi
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2020, 12 (03): : 857 - 866